Itonic Holdings - Class A (ITOC) closed at $3.54 on October 21, 2026, up 5.7% from the previous close, on volume of 2,296 shares (30-day average 672,123).
Data as of October 21, 2026.
iTonic Holdings Ltd Announces 16-for-1 Share Consolidation Effective October 6, 2026
Globe Newswire (Fri, 2-Oct 9:00 AM ET)
Globe Newswire (Mon, 28-Sep 10:13 AM ET)
Globe Newswire (Fri, 25-Sep 1:30 PM ET)
PRNewswire (Thu, 24-Sep 5:40 PM ET)
PRNewswire (Thu, 24-Sep 10:09 AM ET)
PRNewswire (Wed, 23-Sep 10:09 AM ET)
Portnoy Law Firm Announces Class Action on Behalf of iTonic Holdings, Ltd. Investors
Globe Newswire (Tue, 22-Sep 12:54 PM ET)
Globe Newswire (Tue, 22-Sep 11:50 AM ET)
Globe Newswire (Mon, 21-Sep 4:57 PM ET)
iTonic Holdings Ltd through its subsidiary, focuses on healthcare solutions for brachytherapy, a targeted radiation therapy used in cancer treatment. Its product, Beijing Feitian's Treatment Planning System, helps ensure safe and effective brachytherapy using radioactive sources inside the patient to kill cancer cells and shrink tumors. Its product portfolio also includes Medical Auxiliary Supplies such as seed implant needles, computer workstations, patient positioning device, etc.
Itonic Holdings - Class A trades on the NASDAQ stock market under the symbol ITOC.
As of October 21, 2026, ITOC stock price climbed to $3.54 with 2,296 million shares trading.
ITOC has a beta of -0.00, meaning it tends to be less sensitive to market movements. ITOC has a correlation of 0.00 to the broad based SPY ETF.
ITOC has a market cap of $25.90 million. This is considered a Sub-Micro Cap stock.
ITOC support price is $3.04 and resistance is $3.66 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ITOC shares will trade within this expected range on the day.
